ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1120

Hospitalizations Among Patients on Hemodialysis with Limited Mobility in Qatar

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Ibrahem, Mahmoud Suliman Mohammed Salih, Hamad Medical Corporation, Doha, Qatar
  • Abdelhameed, Moayad Hamadelneil Ali, Hamad Medical Corporation, Doha, Qatar
  • Ibrahim, Rania Abdelaziz, Hamad Medical Corporation, Doha, Qatar
  • Mohamed, Mohamed, Hamad Medical Corporation, Doha, Qatar
  • Mathew, Mincy, Hamad Medical Corporation, Doha, Qatar
  • Ateya, Heba Mohamed, Hamad Medical Corporation, Doha, Qatar
  • Hamad, Abdullah Ibrahim, Hamad Medical Corporation, Doha, Qatar
  • Alkadi, Mohamad M., Hamad Medical Corporation, Doha, Qatar
  • Al-Malki, Hassan A., Hamad Medical Corporation, Doha, Qatar
Background

Patients on hemodialysis (HD) have a higher risk of hospitalization in comparison with the general population, especially if these patients have limited mobility. Limited data exist in this population. Our study objectives were to evaluate the incidence, risk factors, causes, and outcomes of hospitalization among HD patients with limited mobility.

Methods

Our study is a single-center retrospective cohort study. The data was collected from electronic medical records. We included all HD patients with severe immobility (bedridden) or mild-moderate immobility (wheelchair bound or significant use of walking devices). The study period included hospitalizations from June 2023 to June 2024, with a 6-month follow-up period till December 2024.

Results

A total of 88 HD patients with limited mobility were included. Age was 65.6 +/- 10.3 years. Body mass index 32.2 +/- 8. During the study period, 50 of 88 patients (56.8%) required one or more hospitalizations (average of 1.84 admissions per hospitalized patient and 1.05 admissions per patient overall). The rate of Re-admissions within 30 days was 9.8%. ICU admission was required in 9 hospitalizations (9.8% of admissions). Infections and HD-related causes were the leading causes of hospitalization (41.3% and 21.7%, respectively). Fourteen patients died during the study period (mortality rate of 15.9%).
Patients with severe immobility had a trend for higher hospitalization burden compared to mild-moderate immobility. In comparison, ICU admission and mortality rate were significantly higher with severe immobility (45% vs. 7.6% and 38.5% vs. 2.5%, respectively, p<003) with death OR 9.98 (95% CI 2.81–35.47, p = 0.000071).

Conclusion

Our study showed that severe immobility was strongly associated with higher ICU admission and mortality. HD patients with limited mobility had a trend for high hospitalization burden, mainly due to infections and HD-related causes. These outcomes highlight the need for targeted preventive care and closer follow-up in this high-risk group.

Acknowledgment

I would like to express my sincere gratitude to my mentors for their continuous guidance, encouragement, and support throughout this work. I am also deeply thankful to the Hemodialysis Team for their dedication, hard work, and invaluable efforts in collecting and organizing the data.